Evaluation of the effectiveness of a mobile app for self-management of hypertension

Designing a mobile app for the control of essential hypertension, based on the PRECEDE-PROCEED model, and evaluation of its effectiveness on patients’ self-management compared to the usual care

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT2015111712211N2

Enrollment

132

Registered

2016-01-01

Start date

2016-02-04

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

primary hypertension. Essential (primary) hypertension

Interventions

Interventions: Intervention group: Intervention group one, in addition to the usual care, the educational – supportive intervention (usual care plus intervention) will be carried out by installing the

Prevention

Eligibility

Sex/Gender

All

Age

30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria:The diagnosis of essential hypertension, without its complications, such as cardiovascular accidents etc ; Being medically treated for hypertension ; Age of patients between 30 and 60 years ; Having a Smartphone and/or tablet ; The ability to read Persian ; Inclination to participate in the study ; Intention to reside in the site of study for the next 6 months Exclusion criteria: Presence of other cardiovascular diseases ; Diabetes mellitus ; Physical disability

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Adherence to hypertensive drug use. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: Hill bone questionnaire.;Adherence to the DASH diet and sodium reduction. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: questionnaire.;Hypertension. Timepoint: Before the intervention and upon every visit – the blood pressures recorded in the application. Method of measurement: Mercury sphygmomanometer.;Regular monitoring of blood pressure. Timepoint: three times in week. Method of measurement: register in application.;Predisposing –enabling & reinforcing factors of adherence to treatment of primary hypertensive patients. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: questionnaire.	—

Measure

Time frame

Adherence to hypertensive drug use. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: Hill bone questionnaire.;Adherence to the DASH diet and sodium reduction. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: questionnaire.;Hypertension. Timepoint: Before the intervention and upon every visit – the blood pressures recorded in the application. Method of measurement: Mercury sphygmomanometer.;Regular monitoring of blood pressure. Timepoint: three times in week. Method of measurement: register in application.;Predisposing –enabling & reinforcing factors of adherence to treatment of primary hypertensive patients. Timepoint: Before the intervention – two months after the intervention – 6 months after the intervention. Method of measurement: questionnaire.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Ashoorkhani

Faculty of Health-Tehran University of Medical Sciences

ashoorkhani1392@yahoo.com+98 21 4293 3333

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Mar 12, 2026